Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
By A. Badawi, S. Ryoo. International Journal of Infectious Diseases, 2016
691 citations recorded by the source corpus.
Highlights • This is a study on the prevalence of chronic diseases in 637 severe Middle East respiratory syndrome coronavirus (MERS-CoV) cases.• Diabetes and hypertension are equally prevalent in approximately 50% of the severe cases.• Cardiac diseases and obesity are present in 30% and 16% of the cases, respectively.• Chronic diseases, in addition to MERS-CoV, further impair the host's innate immunity.• Public health vaccination for MERS-CoV should target subjects with chronic disorders.
Subfields: Epidemiology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/58be2d3cedd4cc034c3e6fd955d74bf4a0428a4c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- COVID-19 and the cardiovascular system (2020, background): “Patients with pre-existing CVD A meta-analysis showed that MERS-CoV infection was more likely to occur in patients with underlying CVD 8 .”
- COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis (2020, result): “There are some studies that showed MERS‐COV and SARS‐COV have also been found to infect more males than females.(22,23) The reduced susceptibility of females to viral infections could be attributed to the protection from X chromosome and sex hormones, which play an essential role in innate and adapt”
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis (2020, background): “The comorbidities effect had also been noted to have similar effects in other respiratory illnesses, such as MERS-CoV 11 .”
- Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships (2020, background): “dle East respiratory syndrome coronavirus (MERS-CoV) in 2012 exhibited high prevalence among individuals with obesity.(108) The growing evidence detailed above demonstrates that obesity increases”
- COVID-19 and comorbidities: Deleterious impact on infected patients (2020, background): “CVD and COVID-19 CVD had a strong relationship with SARS (8%) and MERS (30%) [27,28].”
- Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis (2020, background): “We also found that smokers are more susceptible to Coronavirus infections, especially to the most recent species.”
- Coronaviruses and the cardiovascular system: acute and long-term implications (2020, background): “Furthermore, the severity of the primary respiratory syndrome and risk of adverse outcomes is increased in patients with pre-existing cardiovascular diseases.(11) Hypotension, tachycardia, bradycardia, arrhythmia, or even sudden cardiac death are common in patients with SARS.”
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations (2020, background): “7 in diabetic cohort [6] as compared to overall population.”
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis (2020, background): “A number of existing literature reports have documented the escalated risks of poorer clinical outcomes in patients with avian influenza [14-18], SARS-CoV [19] and MERS-CoV infections [20-28].”